Xpert bladder cancer monitor test for bladder cancer surveillance

Xpert bladder cancer monitor for the surveillance of patients with a previous history of non-muscle invasive bladder cancer: a diagnostic accuracy study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN37210907

Enrollment

150

Registered

2017-03-15

Start date

2017-01-01

Completion date

Unknown

Last updated

2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-muscle invasive bladder cancer Cancer Non-muscle invasive bladder cancer

Interventions

Following provision of informed consent to participate, participants attend routine appointments as part of their usual care every three months for the first two years after first diagnosis of bladder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over 2. Previous history of non-muscle invasive bladder cancer

Exclusion criteria

Exclusion criteria: 1. Muscle-invasive bladder cancer 2. Primary diagnosis of bladder cancer 3. Aged under 18 years

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of the Xpert Bladder Cancer monitor to detect bladder cancer recurrence is assessed by measuring sensitivity, specificity, NPV and PPV	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Austria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026